| 2570 |
18: Activation, AhR |
1241: Increased, Motility |
Feb 15, 2022 |
Feb 29, 2024 |
1 AOP
|
| 2571 |
18: Activation, AhR |
1190: Increased, Migration (Endothelial Cells) |
Feb 15, 2022 |
Feb 29, 2024 |
1 AOP
|
| 2572 |
18: Activation, AhR |
1196: Increased, Invasion |
Feb 15, 2022 |
Mar 5, 2024 |
1 AOP
|
| 2687 |
18: Activation, AhR |
2021: Increase, slincR expression |
Jun 30, 2022 |
Jun 30, 2022 |
None
|
| 2688 |
18: Activation, AhR |
2020: Decrease, sox9 expression |
Jun 30, 2022 |
Apr 13, 2023 |
2 AOPs
|
| 2689 |
18: Activation, AhR |
1559: Smaller and morphologically distorted facial cartilage structures |
Jun 30, 2022 |
Apr 13, 2023 |
1 AOP
|
| 2765 |
18: Activation, AhR |
317: Altered, Cardiovascular development/function |
Sep 27, 2022 |
Oct 21, 2022 |
1 AOP
|
| 2883 |
18: Activation, AhR |
295: Induction, Upregulation of glucuronyltransferase activity |
Apr 12, 2023 |
Apr 12, 2023 |
1 AOP
|
| 2888 |
18: Activation, AhR |
345: N/A, Liver Steatosis |
Apr 13, 2023 |
Apr 13, 2023 |
None
|
| 3219 |
18: Activation, AhR |
459: Increase, Liver steatosis |
May 14, 2024 |
Jan 30, 2025 |
1 AOP
|
| 3482 |
18: Activation, AhR |
1883: Decreased, ovarian reserve |
Jan 22, 2025 |
Jan 22, 2025 |
None
|
| 3533 |
18: Activation, AhR |
2323: Over-expression of PD-L1 in cancer cells |
May 16, 2025 |
Feb 25, 2026 |
1 AOP
|
| 750 |
9: Activation, 5HT2c |
294: N/A, Unknown |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1438 |
1336: Activation, 5-HT2A |
1337: Activate, PLC |
Apr 14, 2017 |
Apr 14, 2017 |
2 AOPs
|
| 1375 |
1288: Activation, 3-hydroxy-3-methylglutaryl-CoA reductase gene |
1289: Perturbation of cholesterol |
Feb 15, 2017 |
Feb 15, 2017 |
1 AOP
|
| 2986 |
2163: Activation Sema6A |
2164: Activation, Dll4-Notch pathway |
Aug 20, 2023 |
Aug 20, 2023 |
1 AOP
|
| 2600 |
1974: Activation of TP53 |
1365: Increase, Apoptosis |
Mar 9, 2022 |
Mar 9, 2022 |
None
|
| 2601 |
1974: Activation of TP53 |
1560: Cell differentiation, altered |
Mar 17, 2022 |
Mar 17, 2022 |
None
|
| 2606 |
1974: Activation of TP53 |
1979: Premature differentiation |
Mar 21, 2022 |
Mar 21, 2022 |
1 AOP
|
| 3105 |
1974: Activation of TP53 |
1262: Apoptosis |
Jan 10, 2024 |
Jan 10, 2024 |
1 AOP
|
| 319 |
288: Activation of specific nuclear receptors, Transcriptional change |
357: Cholestasis, Pathology |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1071 |
1028: Activation of specific nuclear receptors, PPAR-gamma activation |
1029: Increased, adipogenesis |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1072 |
1028: Activation of specific nuclear receptors, PPAR-gamma activation |
1032: Increased, secretion of local growth factors |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1609 |
1028: Activation of specific nuclear receptors, PPAR-gamma activation |
1449: increased adipogenesis |
Jul 24, 2017 |
Jul 24, 2017 |
1 AOP
|
| 3711 |
1028: Activation of specific nuclear receptors, PPAR-gamma activation |
202: Inhibition, Nuclear factor kappa B (NF-kB) |
Jan 16, 2026 |
Jan 16, 2026 |
1 AOP
|